Larry Zeitlin

7.2k total citations
90 papers, 3.5k citations indexed

About

Larry Zeitlin is a scholar working on Infectious Diseases, Biotechnology and Immunology. According to data from OpenAlex, Larry Zeitlin has authored 90 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 39 papers in Biotechnology and 28 papers in Immunology. Recurrent topics in Larry Zeitlin's work include Transgenic Plants and Applications (39 papers), Viral Infections and Outbreaks Research (27 papers) and Viral gastroenteritis research and epidemiology (21 papers). Larry Zeitlin is often cited by papers focused on Transgenic Plants and Applications (39 papers), Viral Infections and Outbreaks Research (27 papers) and Viral gastroenteritis research and epidemiology (21 papers). Larry Zeitlin collaborates with scholars based in United States, Canada and United Kingdom. Larry Zeitlin's co-authors include Kevin J. Whaley, Richard A. Cone, Michael Pauly, Thomas R. Moench, Gene G. Olinger, Andrew Hiatt, Ognian Bohorov, Natasha Bohorova, Timothy E. Hoen and James Pettitt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Larry Zeitlin

89 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Larry Zeitlin United States	32	1.5k	1.1k	1.1k	840	766	90	3.5k
M. Louise M. Pitt United States	34	1.5k 1.0×	2.1k 1.9×	467 0.4×	704 0.8×	534 0.7×	80	3.7k
Peder Worning Denmark	24	844 0.6×	1.9k 1.7×	185 0.2×	339 0.4×	938 1.2×	46	2.9k
Vidadi Yusibov United States	41	983 0.7×	3.0k 2.6×	3.0k 2.6×	639 0.8×	1.0k 1.3×	108	5.1k
Jan‐Ingmar Flock Sweden	36	2.1k 1.4×	2.1k 1.9×	329 0.3×	431 0.5×	439 0.6×	104	4.0k
Conrad P. Quinn United States	38	750 0.5×	2.5k 2.2×	448 0.4×	320 0.4×	237 0.3×	92	3.2k
Bruce E. Ivins United States	33	1.3k 0.9×	3.5k 3.1×	664 0.6×	432 0.5×	392 0.5×	55	4.1k
Susan L. Welkos United States	46	1.1k 0.8×	4.0k 3.5×	650 0.6×	509 0.6×	402 0.5×	111	5.7k
Roland Grunow Germany	34	565 0.4×	2.2k 1.9×	197 0.2×	344 0.4×	403 0.5×	160	3.6k
William C. Weldon United States	35	1.4k 0.9×	448 0.4×	160 0.1×	833 1.0×	525 0.7×	105	3.4k
Nigel J. Dimmock United Kingdom	41	1.6k 1.1×	1.4k 1.2×	270 0.2×	2.6k 3.2×	1.3k 1.7×	171	5.2k

Countries citing papers authored by Larry Zeitlin

Since Specialization

Citations

This map shows the geographic impact of Larry Zeitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry Zeitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry Zeitlin more than expected).

Fields of papers citing papers by Larry Zeitlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry Zeitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry Zeitlin. The network helps show where Larry Zeitlin may publish in the future.

Co-authorship network of co-authors of Larry Zeitlin

This figure shows the co-authorship network connecting the top 25 collaborators of Larry Zeitlin. A scholar is included among the top collaborators of Larry Zeitlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry Zeitlin. Larry Zeitlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Togami, Kohei, Whitney Wolf, Limei Shen, et al.. (2024). Impact of mAb-FcRn affinity on IgG transcytosis across human well-differentiated airway epithelium. Frontiers in Immunology. 15. 1371156–1371156. 2 indexed citations

Politch, Joseph A., Susan Cu‐Uvin, Thomas R. Moench, et al.. (2021). Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial. PLoS Medicine. 18(2). e1003495–e1003495. 40 indexed citations

Zeitlin, Larry, Robert W. Cross, Joan B. Geisbert, et al.. (2021). Therapy for Argentine hemorrhagic fever in nonhuman primates with a humanized monoclonal antibody. Proceedings of the National Academy of Sciences. 118(11). 14 indexed citations

Whaley, Kevin J. & Larry Zeitlin. (2021). Emerging antibody-based products for infectious diseases: Planning for metric ton manufacturing. Human Vaccines & Immunotherapeutics. 18(2). 1930847–1930847. 19 indexed citations

Swope, Kelsi, Josh Morton, Gregory P. Pogue, et al.. (2021). Manufacturing plant-made monoclonal antibodies for research or therapeutic applications. Methods in enzymology on CD-ROM/Methods in enzymology. 660. 239–263. 8 indexed citations

Cross, Robert W., Zachary A. Bornholdt, Abhishek N. Prasad, et al.. (2021). Combination therapy protects macaques against advanced Marburg virus disease. Nature Communications. 12(1). 1891–1891. 56 indexed citations

Moyer, Crystal L., Dafna M. Abelson, Daniel J. Deer, et al.. (2020). Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38. Journal of Virology. 94(8). 32 indexed citations

Varrone, John J., Graham G. Willsey, Michael Pauly, et al.. (2020). Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies. PLoS neglected tropical diseases. 14(3). e0007803–e0007803. 22 indexed citations

Roy, Chad J., Greta Van Slyke, Dylan Ehrbar, et al.. (2020). Passive immunization with an extended half-life monoclonal antibody protects Rhesus macaques against aerosolized ricin toxin. npj Vaccines. 5(1). 13–13. 11 indexed citations

10.

Yang, Bing, Alison Schaefer, Yingying Wang, et al.. (2018). ZMapp Reinforces the Airway Mucosal Barrier Against Ebola Virus. The Journal of Infectious Diseases. 218(6). 901–910. 26 indexed citations

11.

Schroeder, Holly A., Kenetta L. Nunn, Alison Schaefer, et al.. (2018). Herpes simplex virus-binding IgG traps HSV in human cervicovaginal mucus across the menstrual cycle and diverse vaginal microbial composition. Mucosal Immunology. 11(5). 1477–1486. 31 indexed citations

12.

Mire, Chad E., Joan B. Geisbert, Viktoriya Borisevich, et al.. (2017). Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody. Science Translational Medicine. 9(384). 69 indexed citations

13.

Anderson, Deborah J., Joseph A. Politch, Larry Zeitlin, et al.. (2017). Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV. AIDS. 31(11). 1505–1517. 21 indexed citations

14.

Pauly, Michael, Do H. Kim, Ognian Bohorov, et al.. (2015). Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide. Journal of Immunological Methods. 422. 111–117. 8 indexed citations

15.

Kugelman, Jeffrey R., Jason T. Ladner, J. R. Pettit, et al.. (2015). Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody Cocktail. Cell Reports. 12(12). 2111–2120. 50 indexed citations

16.

Zeitlin, Larry, Ognian Bohorov, Natasha Bohorova, et al.. (2013). Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model. mAbs. 5(2). 263–269. 24 indexed citations

17.

O’Hara, Joanne M., Kevin J. Whaley, Michael Pauly, Larry Zeitlin, & Nicholas J. Mantis. (2011). Plant-based expression of a partially humanized neutralizing monoclonal IgG directed against an immunodominant epitope on the ricin toxin A subunit. Vaccine. 30(7). 1239–1243. 30 indexed citations

18.

Zeitlin, Larry, et al.. (2002). Preventing Sexual Transmission of HSV and HIV: the Challenge for Active and Passive Immunization of Mucosal Surfaces. Biotechnology and Genetic Engineering Reviews. 19(1). 121–138. 2 indexed citations

19.

Zeitlin, Larry, Richard A. Cone, Thomas R. Moench, & Kevin J. Whaley. (2000). Preventing infectious disease with passive immunization. Microbes and Infection. 2(6). 701–708. 67 indexed citations

20.

Zeitlin, Larry, Philip E. Castle, Kevin J. Whaley, Thomas R. Moench, & Richard A. Cone. (1998). Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina. Journal of Reproductive Immunology. 40(1). 93–101. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact